Holiday Sale | Save 50%
SubscribeLogin
Holiday Sale | Save 50%
Published

Esperion Outlines Upcoming Milestones and Announces Preliminary Fourth Quarter 2022 Financial Results - Esperion Therapeutics (NASDAQ:ESPR)

Summary by Ground News
Nova expects to release its financial results for the fourth quarter and full year of 2022 before the Nasdaq market opens on February 15, 2023. Eitan Oppenhaim, President and Chief Executive Officer, and Dror David, Chief Financial Officer, will host a conference call to review the Company's financial results. The conference call will be available via a live webcast from a link on Nova's Investor Relations website.
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 67% of the sources are Center
67% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)

Similar News Topics

BusinessBusiness
FinanceFinance
Trending Topics
App Store IconPlay Store Icon
CompanyAboutHistoryMissionBlogTestimonialsGroup SubscriptionsSubscribeGiftFree TrialCareersAffiliates
HelpHelp CenterFAQContact UsFor Educators/LibrariesMedia Bias RatingsOwnership and Factuality RatingsReferral CodeNews SourcesTopics
ToolsAppBrowser ExtensionDaily NewsletterBlindspot Report NewsletterBurst Your Bubble NewsletterTimelines
DonatePrivacy PolicyManage CookiesTerms and Conditions
© 2024 Snapwise Inc
News
For You
Search
BlindspotLocal